Today we’re announcing our $60 million Series C, led by Spark Capital, with continued support from Activant Capital, Industry Ventures, Pear VC, and others. This brings our total funding to more than $170 million. Spark has a history of backing companies that reshape industries — including Slack, Twitter, and Coinbase — and notably led Anthropic’s $450 million Series C in 2023.
Companies like Coinbase, Bilt, Qatar Airways, and Alibaba are already building with Cardless, proving what’s possible when credit is embedded directly into products. We believe the next decade of financial services will be built this way — and we’re building the infrastructure to make that happen.
Read More – Sevaro Health Raises $39M in Series B Funding
Traditional credit programs were designed around banks. They take years to launch, rely on rigid systems, and leave companies with little control over the customer experience.Those models left billions on the table, because companies never had the tools to design credit on their own terms.
We remove those compromises. With our APIs and prebuilt components, companies can design every touchpoint of a credit program — from application to rewards to servicing — while we manage the complexity behind the scenes. Customer data and AI make decisioning smarter, and new cards launch in months, not years. The result is credit that feels native to the product, not an afterthought. With that control, companies unlock loyalty, revenue, and rewards people value.
Cards built with us have grown transactions 400% year over year. Cardholders spend significantly more with cards offered by Cardless than those issued by legacy banks.
With this funding, we’ll expand existing cards, launch new ones with companies like Bilt, and introduce more financial products — all designed for companies to stay in control and deliver better experiences to their customers.
Our mission hasn’t changed. We enable product-first companies to build financial power into their experience — with control, speed, and outcomes only they can deliver.
Read More – Avenzo Therapeutics Raised $60M in Series B Funding
